Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Positive phase II results reported for platelet substitute

Jan. 24, 1997

Additional beneficial lipid-modifying effects of FCP-3P1 reported

Jan. 24, 1997

Cerebrus discovers role of gene in obesity

Jan. 24, 1997

Inhibitors of alpha-amylase disclosed by Japanese researchers

Jan. 23, 1997

ACAT inhibitors from Takeda

Jan. 23, 1997

NESP enters clinical trials

Jan. 22, 1997

Ergo readying first NDA submission

Jan. 22, 1997

Research supports development of Houghten lead compound

Jan. 22, 1997

Asta seeks rights to impotency Rx

Jan. 21, 1997

First market introductions for Bondronat

Jan. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...